TLPHTalphera, Inc.

$18M

Q3 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1,000

Gross Profit

$1,000100.0% margin

Operating Income

-$3M-342200.0% margin

Net Income

-$4M-443600.0% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$152,000

Balance Sheet

Total Assets

$31M

Total Liabilities

$12M

Stockholders' Equity

$19M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1,000	$0	—
Gross Profit	$1,000	-$2M	+100.0%
Operating Income	-$3M	-$4M	+8.7%
Net Income	-$4M	-$3M	-32.3%

TLPH Q3 2025 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena